false
0001901203
0001901203
2026-11-09
2026-11-09
0001901203
UCFI:CommonStockParValue0.0001PerShareMember
2026-11-09
2026-11-09
0001901203
UCFI:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember
2026-11-09
2026-11-09
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)
November 9, 2026
CN Healthy Food Tech Group Corp.
(Exact name of registrant as specified in its
charter)
| Delaware |
|
001-41898 |
|
85-4105289 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
Fuhuali Zhonghai Plaza, Building B, Suite 1001
2021 West Jiuzhou Blvd., Xiangzhou District
Zhuhai City, Guangdong Province, China 519000
(Address, including zip code, of principal executive
offices)
+(86) 0756-8300081
Registrant’s telephone number, including
area code
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common stock, par value $0.0001 per share |
|
UCFI |
|
The Nasdaq Stock Market |
| Warrants, each whole warrant exercisable for one share of Common stock at an exercise price of $11.50 per share |
|
UCFIW |
|
The Nasdaq Stock Market |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing.
As previously disclosed, on July 16, 2026, CN
Healthy Food Tech Group Corp. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”)
of The Nasdaq Stock Market LLC (the “Nasdaq”) stating that the Staff had determined to delist the Company’s common stock,
par value $0.0001 per share (the “Common Stock”), and warrants, each warrant exercisable for one share of Common Stock at
an exercise price of $11.50 per share (the “Warrant,” together with the Common Stock, the “Listed Securities”),
based on Nasdaq Listing Rule 5101 and IM-5101-1 (together, “Rule 5101”) and the Company’s alleged violation of Nasdaq
Listing Rules 5205(e) and 5250(a)(1) (the “Misrepresentation Rules”). The Company appealed, and by letter dated October 7,
2026, the Nasdaq Hearings Panel (the “Panel”) determined to allow the Company to maintain its listing subject to certain conditions.
Trading in the Common Stock was scheduled to resume on October 19, 2026; however, after receiving additional information from the China
Securities Regulatory Commission (the “CSRC”), the Staff continued the trading halt to request additional information from
the Company.
On November 9, 2026, the Company received a letter
(the “Determination Letter”) from Nasdaq whereby the Staff determined to issue an additional delisting determination pursuant
to Rule 5101 and for violation of the Misrepresentation Rules, based on information received from the CSRC, including a letter from the
CSRC to the Staff dated October 30, 2026, which serves as an additional basis for delisting the Listed Securities. The Determination Letter
states that the CSRC made certain allegations regarding, among other things, the status of the Company’s compliance with CSRC filing
requirements, the authenticity of certain materials the Company previously provided to the Staff, the Company’s responsiveness to
CSRC inquiries, and the Company’s PRC counsel.
The Panel will consider this matter in its decision
regarding the Company’s continued listing on The Nasdaq Capital Market. The Company may provide more information to address this
additional deficiency to the Panel in writing no later than November 16, 2026. The Company intends to present its views to the Panel by
that deadline. The trading halt in the Listed Securities remains in effect. There can be no assurance that the Panel will rule in the
Company’s favor, or that the Listed Securities will resume trading or continue to be listed on Nasdaq.
Forward-Looking Statements
Certain statements made in this Current Report
on Form 8-K are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended,
Section 21E of the Securities Exchange Act of 1934, as amended, and the “safe harbor” provisions under the Private Securities
Litigation Reform Act of 1995. All statements other than statements of historical fact included in this Current Report on Form 8-K are
forward-looking statements. When used in this Current Report on Form 8-K, words such as “anticipate,” “believe,”
“continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,”
“plan,” “possible,” “potential,” “predict,” “project,” “should,”
“would” and variations of these words or similar expressions (or the negative versions of such words or expressions), as they
relate to the Company or its management team, are intended to identify forward-looking statements. Many factors could cause actual future
events to differ materially from the forward-looking statements in this Current Report on Form 8-K, including the Company’s ability
to successfully address the Staff’s additional delisting determination before the Panel and the risks associated with delisting
of the Company’s securities from Nasdaq. Such forward-looking statements are based on the beliefs of management, as well as assumptions
made by, and information currently available to, the Company’s management. Forward-looking statements are not guarantees of future
performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors,
many of which are beyond the control of the Company, including those set forth in the “Risk Factors” section of the Company’s
most recent Annual Report on Form 10-K, and other reports and registration statements of the Company filed, or to be filed, with the SEC,
that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. All subsequent
written or oral forward-looking statements attributable to the Company or persons acting on its behalf are qualified in their entirety
by this paragraph. The Company undertakes no obligation to update or revise any forward-looking statements for revisions or changes after
the date of this Current Report on Form 8-K, except as required by law.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
CN HEALTHY FOOD TECH GROUP CORP. |
| |
|
|
| Date: November 13, 2026 |
By: |
/s/ Zhenjun Jiang |
| |
Name: |
Zhenjun Jiang |
| |
Title: |
Chief Executive Officer and Chairman of the Board |